prof. MUDr. Michael Doubek, Ph.D.
Department vice-head, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 863
2009
-
Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine
European Journal of Haematology, year: 2009, volume: 82, edition: 2, DOI
-
Relationship between therapy and clonal evolution of TP53 abnormalities in patients with chronic lymphocytic leukemia
Year: 2009, type: Conference abstract
-
Retention of nanoparticules-labeled bone marrow mononuclear cells in the isolated ex vivo perfused heart after myocardial infarction in animal model
Experimental Biology and Medicine, year: 2009, volume: 234, edition: 2
-
Rituximab in combination with dexamethasone or high-dose methylprednisolone in refractory chronic lymphocytic leukemia
Haematologica, year: 2009, volume: 94, edition: 3
-
Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide
Experimental Hematology, year: 2009, volume: 37, edition: 6, DOI
-
Výsledky léčby nemocných s esenciální trombocytémií a dalšími myeloproliferacemi provázenými trombocytémií-zpráva z registru pacientů léčených Thromboreductinem
Vnitřní Lékařství, year: 2009, volume: 55, edition: 11
-
What do we know about the real incidence of chronic lymphocytic leukemia (CLL) and where and how are the patients with CLL treated?
Haematologica/the hematology journal, year: 2009, volume: 94, edition: s3
-
Where is hematological oncology headed in Central and Eastern European countries?
MedReport, year: 2009, volume: 5, edition: 33
2008
-
Aberantní somatická hypermutace u chronické lymfocytární leukemie: jak (asi) vzniká a k čemu vede
Year: 2008, type: Conference abstract
-
Alemtuzumab v terapii chronické lymfatické leukemie (CLL) - retrospektivní multicentrická analýza a léčebná odpověď podle cytogenetického rizika
Transfuze a hematologie dnes, year: 2008, volume: 14, edition: Suppl.2